EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors

Wenhao Hu, Feng Li, Yue Liang, Shasha Liu, Shumin Wang, Chunyi Shen, Yuyu Zhao, Hui Wang, Yi Zhang

Journal for ImmunoTherapy of Cancer · 2025-01 · 13 (1) · e010540

DOI: 10.1136/jitc-2024-010540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 16.01.2025. Verfasst von Wenhao Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center & Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China. Hauptthemen laut MEDLINE: Glucose Transporter Type 3, Glucose, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Health Commission of Henan Province, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucose deprivation inhibits T-cell metabolism and function. Glucose levels are low in the tumor microenvironment of solid tumors and insufficient glucose uptake limits the antitumor response of T cells. Furthermore, glucose restriction can contribute to the failure of chimeric antigen receptor T (CAR-T) cell therapy for solid tumors. However, the impact of glucose restriction remains unknown in CAR-T cell therapy.

Methods

Glucose transporters were detected and overexpressed in CAR-T cells. The impacts of glucose restriction on CAR-T cells were checked in vitro and in vivo.

Results

Glucose restriction significantly decreased CAR-T cell activation, effector function, and expansion. CAR-T cells expressed high levels of the glucose transporter Glut1, which has a low affinity for glucose. Overexpression of Glut1 failed to improve CAR-T cell function under glucose-restricted conditions. In contrast, the function and antitumor potential of CAR-T cells was enhanced by the overexpression of Glut3, which has the highest affinity for glucose among the Glut transporter family and is expressed in minor parts of CAR-T cells. Glut3-overexpressing CAR-T cells demonstrated increased tumoricidal efficacy in multiple xenografts and syngenetic mouse models. Furthermore, Glut3 overexpression activated the PI3K/Akt pathway and increased OXPHOS and mitochondrial fitness.

Conclusions

We provide a direct and effective approach to enhance low glucose uptake levels by CAR-T cells and improve their antitumor efficacy against solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucose Transporter Type 3GlucoseImmunotherapy, AdoptiveReceptors, Chimeric AntigenNeoplasmsAnimalsHumansMiceTumor MicroenvironmentCell Line, TumorXenograft Model Antitumor AssaysGlucose Transporter Type 1Female

Stichwörter der Autor:innen

Chimeric antigen receptor - CARMitochondriaNutritionSolid tumor

Substanzen

Glucose Transporter Type 3GlucoseSLC2A3 protein, humanReceptors, Chimeric AntigenGlucose Transporter Type 1

Autor:innen und Institutionen

  • Biotherapy Center & Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
  • Biotherapy Center & Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China yizhang@zzu.edu.cn fcclif1@zzu.edu.cn.
  • Zhongyuan Cell Therapy and Immunotherapy Laboratory, Henan Academy of Innovations in Medical Science, Zhengzhou, People's Republic of China.
  • School of Public Health, Zhengzhou University, Zhengzhou, People's Republic of China.

Förderung

  • National Natural Science Foundation of China
  • Health Commission of Henan Province
  • Ministry of Science and Technology of the People's Republic of China
  • Provincial Department of Science and Technology of Henan
  • First Affiliated Hospital of Zhengzhou University

Zitieren

APA

Hu, W., Li, F., Liang, Y., Liu, S., Wang, S., Shen, C., Zhao, Y., Wang, H., & Zhang, Y. (2025). Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors. Journal for ImmunoTherapy of Cancer, 13(1), e010540. https://doi.org/10.1136/jitc-2024-010540

Vancouver

Hu W, Li F, Liang Y, Liu S, Wang S, Shen C, et al. Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors. Journal for ImmunoTherapy of Cancer. 2025;13(1):e010540. doi:10.1136/jitc-2024-010540

BibTeX
@article{Hu2025,
  author = {Hu, Wenhao and Li, Feng and Liang, Yue and Liu, Shasha and Wang, Shumin and Shen, Chunyi and Zhao, Yuyu and Wang, Hui and Zhang, Yi},
  title = {Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {1},
  pages = {e010540},
  doi = {10.1136/jitc-2024-010540}
}
Kostenlos starten →